HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Nov. 2, 2005--Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced today that the Company has secured commitment for $13 million in private equity financing. The funds will be used for general corporate purposes. The private placement of common stock is with institutional investors and is priced at a 3% discount to the market price. There are no warrants with the placement and no restrictions on other corporate financing.
